Proposed Data Collection Submitted for Public Comment and Recommendations, 64475-64476 [2020-22489]
Download as PDF
<![CDATA[
64475
Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices
older, through ABLES at NIOSH. Over
the past several decades there have been
substantial efforts in environmental lead
abatement, improved protection from
occupational lead exposure, and a
reduction in the prevalence of
population blood lead levels (BLLs) over
time. The U.S. population BLLs have
substantially decreased over the last
four decades. For example, the CDC has
reported the 1976–1980 U.S. mean BLL
in children 6 months to 5 years was 16.0
micrograms per deciliter (mcg/dL), and
14.1 mcg/dL among adults 18 to 74
years. More recently, the CDC reported
the 2009–2010 U.S. BLL geometric
elevated BLLs when primary prevention
is not achieved. As of 2015, NCEH
defines its reference level for children at
5 mcg/dL. NIOSH defines an elevated
BLLs as greater than or equal to 5 mcg/
dL for adults.
Respondents are defined as state,
local, and territorial health departments
with lead poisoning prevention
programs. The estimated annual time
burden for NCEH CBLS is 946 hours.
The estimated annual time burden for
NIOSH ABLES is 280 hours. In total,
CDC is requesting approval for a total
annual time burden of 1,226 hours.
means among children 1 to 5 years and
among adults 20 years and older as 1.2
mcg/dL for both age groups.
In 2012, the National Toxicology
Program (NTP) concluded that there is
sufficient evidence that even BLLs less
than 5 mcg/dL are associated with
adverse health effects in both children
and adults. Despite the reduction in the
overall population BLL over four
decades, lead exposures continue to
occur at unacceptable levels for
individuals in communities and
workplaces across the nation.
Surveillance will continue through
CBLS and ABLES to identify cases of
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hr)
Total burden
(in hr)
Form name
State, Local and Territorial Health
Departments, or their Bona Fide
Agents.
CBLS Variables (ASCII Text Files) ..
CBLS Aggregate Records Form
(Excel).
ABLES Case Records Form and
Brief Narrative Report.
ABLES Aggregate Records Form
and Brief Narrative Report.
59
1
4
1
4
2
944
2
32
1
8
256
8
1
3
24
...........................................................
........................
........................
........................
1,226
Total ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–22491 Filed 10–9–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0888; Docket No. CDC–2020–
0102]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Type of respondent
VerDate Sep<11>2014
18:52 Oct 09, 2020
Jkt 253001
proposed information collection project
titled Factors Influencing the
Transmission of Influenza. This
proposed collection is intended to
further our understanding of how
respiratory viruses like influenza are
transmitted from person to person.
DATES: CDC must receive written
comments on or before December 14,
2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0102 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
E:\FR\FM\13OCN1.SGM
13OCN1
64476
Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Factors Influencing the Transmission
of Influenza (OMB Control No. 0920–
0888, Exp. 2/28/2021)—Extension—
National Institute for Occupational
Safety and Health (NIOSH), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The National Institute for
Occupational Safety and Health
(NIOSH) is authorized to conduct
research to advance the health and
safety of workers under Section 20(a)(1)
of the 1970 Occupational Safety and
Health Act. NIOSH is requesting an
extension to an existing ICR (expiring
February 28, 2021) because the ongoing
will be collected and tested for
influenza virus, and the levels of
influenza infection-associated
biomarkers will be measured in blood
samples from these subjects.
Volunteer adult participants will be
recruited by a test coordinator using a
poster and flyers describing the study.
Interested potential participants will be
screened verbally to verify that they
have influenza-like symptoms and that
they do not have any medical
conditions that would preclude their
participation. A matching number of
healthy control participants will also be
recruited. Qualified participants who
agree to participate in the study will be
asked to read and sign an informed
consent form, and then to complete a
short health questionnaire. After
completing the forms, the participant’s
oral temperature will be measured, and
two nasopharyngeal mucus samples and
five ml of blood will be collected. The
participant then will be asked to don an
elastomeric mask and breathe and cough
normally for 40 minutes into an aerosol
particle collection system. The total
time from initial verbal screening to
completion will be about 95 minutes.
The study will require 90 volunteer test
subjects each year for three years, for a
total of 270 test participants. There are
no costs to respondents other than their
time.
COVID–19 pandemic has temporarily
halted the study due to staff safety
concerns and an inability to access
healthcare facilities in order to recruit
test subjects.
Influenza continues to be a major
public health concern because of the
substantial health burden from seasonal
influenza and the potential for a severe
pandemic. Although influenza is known
to be transmitted by infectious
secretions, these secretions can be
transferred from person to person in
many different ways, and the relative
importance of the different pathways is
not known. The likelihood of the
transmission of influenza virus by small
infectious airborne particles produced
during coughing and breathing is
particularly unclear. The question of
airborne transmission is especially
important in healthcare facilities, where
influenza patients tend to congregate
during influenza season, because it
directly impacts the infection control
and personal protective measures that
should be taken by healthcare workers.
The purpose of this study is to gain
a better understanding of the production
of infectious aerosols by patients with
influenza, and to compare this to the
levels of biomarkers of influenza
infection in the blood of these patients.
To do this, airborne particles produced
by volunteer subjects with influenza
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Potential participant
Qualified participant
Qualified participant
Qualified participant
Number of
responses per
respondent
Average
burden per
response
(in hrs.)
Total burden
(in hrs.)
..........................
..........................
..........................
..........................
Initial verbal screening .....................
Informed consent form .....................
Health questionnaire ........................
Medical testing .................................
180
90
90
90
1
1
1
1
3/60
15/60
5/60
72/60
9
23
8
108
Total ...........................................
...........................................................
........................
........................
........................
148
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–22489 Filed 10–9–20; 8:45 am]
BILLING CODE 4163–18–P
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Form name
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–1243; Docket No. CDC–2020–
0105]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
SUMMARY:
VerDate Sep<11>2014
18:52 Oct 09, 2020
Jkt 253001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection entitled ‘‘Rapid Response
Suicide Investigation Data Collection.’’
CDC will use the information collected
to continue providing rapid responses to
urgent requests for CDC assistance in
the investigation of an apparent or
unexplained potential cluster or
increase in suicidal behavior.
E:\FR\FM\13OCN1.SGM
13OCN1
]]>Agencies
[Federal Register Volume 85, Number 198 (Tuesday, October 13, 2020)]
[Notices]
[Pages 64475-64476]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22489]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-0888; Docket No. CDC-2020-0102]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Factors Influencing the
Transmission of Influenza. This proposed collection is intended to
further our understanding of how respiratory viruses like influenza are
transmitted from person to person.
DATES: CDC must receive written comments on or before December 14,
2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0102 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7118; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the
[[Page 64476]]
proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Factors Influencing the Transmission of Influenza (OMB Control No.
0920-0888, Exp. 2/28/2021)--Extension--National Institute for
Occupational Safety and Health (NIOSH), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The National Institute for Occupational Safety and Health (NIOSH)
is authorized to conduct research to advance the health and safety of
workers under Section 20(a)(1) of the 1970 Occupational Safety and
Health Act. NIOSH is requesting an extension to an existing ICR
(expiring February 28, 2021) because the ongoing COVID-19 pandemic has
temporarily halted the study due to staff safety concerns and an
inability to access healthcare facilities in order to recruit test
subjects.
Influenza continues to be a major public health concern because of
the substantial health burden from seasonal influenza and the potential
for a severe pandemic. Although influenza is known to be transmitted by
infectious secretions, these secretions can be transferred from person
to person in many different ways, and the relative importance of the
different pathways is not known. The likelihood of the transmission of
influenza virus by small infectious airborne particles produced during
coughing and breathing is particularly unclear. The question of
airborne transmission is especially important in healthcare facilities,
where influenza patients tend to congregate during influenza season,
because it directly impacts the infection control and personal
protective measures that should be taken by healthcare workers.
The purpose of this study is to gain a better understanding of the
production of infectious aerosols by patients with influenza, and to
compare this to the levels of biomarkers of influenza infection in the
blood of these patients. To do this, airborne particles produced by
volunteer subjects with influenza will be collected and tested for
influenza virus, and the levels of influenza infection-associated
biomarkers will be measured in blood samples from these subjects.
Volunteer adult participants will be recruited by a test
coordinator using a poster and flyers describing the study. Interested
potential participants will be screened verbally to verify that they
have influenza-like symptoms and that they do not have any medical
conditions that would preclude their participation. A matching number
of healthy control participants will also be recruited. Qualified
participants who agree to participate in the study will be asked to
read and sign an informed consent form, and then to complete a short
health questionnaire. After completing the forms, the participant's
oral temperature will be measured, and two nasopharyngeal mucus samples
and five ml of blood will be collected. The participant then will be
asked to don an elastomeric mask and breathe and cough normally for 40
minutes into an aerosol particle collection system. The total time from
initial verbal screening to completion will be about 95 minutes. The
study will require 90 volunteer test subjects each year for three
years, for a total of 270 test participants. There are no costs to
respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Potential participant......... Initial verbal 180 1 3/60 9
screening.
Qualified participant......... Informed consent 90 1 15/60 23
form.
Qualified participant......... Health 90 1 5/60 8
questionnaire.
Qualified participant......... Medical testing. 90 1 72/60 108
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 148
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-22489 Filed 10-9-20; 8:45 am]
BILLING CODE 4163-18-P
